DM
DiaMedica Therapeutics
DMAC·NASDAQMinneapolis MNFounded 200015 employees
Micro CapbiotechPublicNeurologyNephrology
Platform: DM199 KLK1
Market Cap
$0.06B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (DMAC)
Loading DMAC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DMA-2916 | DMA-2916 | Phase 1/2 | 2 | CD38 | ADPKDHeart Failure | ||
| Doxaderotide | DMA-6746 | Phase 1/2 | 2 | FcRn | CRC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)